This page shows the latest Clementia Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Will acquire lead multiple rare disease candidate palovarotene. Ipsen is set to pay out a total of $1.3bn to buy Clementia Pharmaceuticals in a move that will significantly boost its ... The acquisition of Clementia Pharmaceuticals accelerates the
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...